GlassScriptPhysician profile
Jacqueline P Apgar
NPI 1013908516
$1,009.03
in general payments reported to CMS, 2019-2025
14 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $57.12 · 2021: $17.41 · 2023: $83.68 · 2024: $222 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $223.88 | 2023-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Novasure |
| Organon LLC | $222.35 | 2024 | |
| Allergan, INC. | $164.13 | 2019-2020 | |
| Myriad Women'S Health, INC. | $68.93 | 2023 | Myrisk |
| Abbvie INC. | $58.32 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.63 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $49.18 | 2019 | |
| Coopersurgical, INC. | $48.52 | 2019-2025 | Paragard T 380a |
| Pfizer INC. | $37.81 | 2021-2025 | |
| Roche Diagnostics Corporation | $22.84 | 2019 | |
| Amag Pharmaceuticals, INC. | $21.61 | 2019 | |
| Lupin INC. | $17.11 | 2019 | |
| Sage Therapeutics, LLC | $16.72 | 2025 | Zurzuvae |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Apgar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.